jain.com

Senior secured credit facilities

Company: Core Scientific

Subject kind
financing
Statement date
2026-08-27
Promised amount
600.0 USD
Current status
verified

The claim, verbatim

Core Scientific entered into $600 million of committed senior secured credit facilities, consisting of a $100 million revolving credit facility and $500 million letter of credit facility

Source (primary)

Core Scientific Secures $600 Million of Senior Secured Credit Facilities - Core Scientific (-, news_article)
View cached copy (2026-09-02)Live source ↗Archive.org ↗

Quote: “it has entered into $600 million of committed senior secured credit facilities, consisting of a $100 million revolving credit facility and $500 million letter of credit facility”

How we checked this

Checked on October 10, 2026. The cited source supports every part of this claim.

Core Scientific's August 27, 2026 press release states it entered into $600 million of committed senior secured credit facilities made up of a $100 million revolver and a $500 million letter of credit facility.

Confirmed in the source:

What we did: Read our cached copy of the publisher (https://investors.corescientific.com/news-events/press-releases/detail/143/core-scientific-secures-600-million-of-senior-secured-credit-facilities) in full (8,112 characters, retrieved September 2, 2026) and checked each assertion in the claim against it.

Additional evidence

confirms Core Scientific Secures $600 Million of Senior Secured Credit Facilities - Core Scientific

Quote: “it has entered into $600 million of committed senior secured credit facilities, consisting of a $100 million revolving credit facility and $500 million letter of credit facility”

View cached copy (2026-09-02)Live source ↗Archive.org ↗

confirms Core Scientific (CORZ) Is Down 5.6% After Securing $600M In New Credit Facilities And Liquidity Release - simplywall.st

Quote: “On 27 August 2026, Core Scientific, Inc. secured US$600 million in committed senior secured credit facilities, including a US$100 million revolving credit line and a US$500 million letter of credit facility, which are backed by first-priority liens on substantially all company and guarantor assets.”

View cached copy (2026-09-02)Live source ↗Archive.org ↗

confirms Core Scientific Secures New $600 Million Credit Facilities - The Globe and Mail

Quote: “On August 25, 2026, Core Scientific Inc . entered into a senior secured credit agreement establishing a $100 million revolving credit facility and a $500 million letter-of-credit facility”

View cached copy (2026-09-02)Live source ↗Archive.org ↗

confirms Core Scientific (CORZ) Is Down 5.6% After Securing $600M In New Credit Facilities And Liquidity Release - simplywall.st

Quote: “On 27 August 2026, Core Scientific, Inc. secured US$600 million in committed senior secured credit facilities, including a US$100 million revolving credit line and a US$500 million letter of credit facility, which are backed by first-priority liens on substantially all company and guarantor assets.”

View cached copy (2026-09-04)Live source ↗Archive.org ↗

confirms Core Scientific Completes Polaris DS Acquisition for $444 Million in Cash - marketscreener.com

Quote: “Core Scientific, Inc. Secures $600 Million Of Senior Secured Credit Facilities”

View cached copy (2026-08-31)Live source ↗

confirms Core Scientific (CORZ) legal chief sold 10,000 shares under a prearranged trading plan. - Stock Titan

Quote: “Core Scientific Secures $600 Million of Senior Secured Credit Facilities”

View cached copy (2026-09-24)Live source ↗

confirms Core Scientific Names Jay Elms as Chief Commercial Officer - marketscreener.com

Quote: “Core Scientific, Inc. Secures $600 Million Of Senior Secured Credit Facilities”

View cached copy (2026-09-26)Live source ↗

Record of changes

September 2, 2026 — stated
Automated extraction from the cited source. Recorded automatically from the cited source when it was published, then queued for evidence review.
October 9, 2026 — verified
Automated extraction from the cited source. Recorded automatically from the cited source when it was published, then queued for evidence review.